Roles of metalloproteases in metastatic niche
- PMID: 21707518
- DOI: 10.2174/156652411797536705
Roles of metalloproteases in metastatic niche
Abstract
Metalloproteinases (MMPs) are a cluster of at least 23 enzymes belonging to the more wide family of endopeptidases called Metzincins, whose structure is characterized by the presence of a zinc ion at the catalytic site. Although the general view of MMPs as physiologic scissors involved in extracellular matrix (ECM) degradation and tissue remodeling is still valid, additional functions have recently emerged, including the ability to cleave non ECM molecules such as growth factors, cytokines and chemokines from their membrane-anchored proforms. These functions are utilized by tumor cells and are fundamental in the determination of tumor progression and invasion. The effect of MMPs activity in cancer progression has been traditionally associated with the acquisition by tumor cells of an invasive phenotype, an indispensable requisite for the metastatic spreading of cancer cells. In addition to the traditional view, a new role for MMPs in creating a favourable microenvironment has been proposed, so that MMPs are not only involved in cell invasion, but also in signaling pathways that control cell growth, inflammation, or angiogenesis. Finally, recent evidence suggest a role of MMPs in the so called "pre-metastatic niche" that is the hypothesis of an early distant modification of the premetastatic site by primary cancer cells. This new hypothesis is changing our traditional view about MMPs and provides important insights into the effective time window for the therapeutic use of MMP inhibitors. In this review we provide the main available data about the ability of MMPs in creating a suitable microenvironment for tumor growth in metastatic sites and we indicate the implication of these data on the potential use of MMP inhibitors in the metastatic therapy.
Similar articles
-
Matrix metalloproteinases and metastasis.Cancer Chemother Pharmacol. 1999;43 Suppl:S42-51. doi: 10.1007/s002800051097. Cancer Chemother Pharmacol. 1999. PMID: 10357558 Review.
-
Matrix metalloproteinases and cancer - roles in threat and therapy.Asian Pac J Cancer Prev. 2014;15(3):1085-91. doi: 10.7314/apjcp.2014.15.3.1085. Asian Pac J Cancer Prev. 2014. PMID: 24606423 Review.
-
[Role of metalloproteinases and their inhibitors in tumors].Medicina (B Aires). 2012;72(6):495-502. Medicina (B Aires). 2012. PMID: 23241294 Review. Spanish.
-
[The significance of metalloproteinases and their inhibitors in gastric cancer].Postepy Hig Med Dosw (Online). 2009 Jun 5;63:258-65. Postepy Hig Med Dosw (Online). 2009. PMID: 19502687 Review. Polish.
-
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19. Biochim Biophys Acta Mol Cell Res. 2017. PMID: 28636874 Review.
Cited by
-
Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre-metastatic niches.Mol Carcinog. 2020 Mar;59(3):323-332. doi: 10.1002/mc.23157. Epub 2020 Jan 14. Mol Carcinog. 2020. PMID: 31943365 Free PMC article.
-
Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion.Mol Cancer. 2012 Oct 21;11:79. doi: 10.1186/1476-4598-11-79. Mol Cancer. 2012. PMID: 23083134 Free PMC article.
-
Deficiency of CCAAT/enhancer binding protein family DNA binding prevents malignant conversion of adenoma to carcinoma in NNK-induced lung carcinogenesis in the mouse.Mol Cancer. 2012 Dec 12;11:90. doi: 10.1186/1476-4598-11-90. Mol Cancer. 2012. PMID: 23234329 Free PMC article.
-
Transcriptomics of mussel transmissible cancer MtrBTN2 suggests accumulation of multiple cancer traits and oncogenic pathways shared among bilaterians.Open Biol. 2023 Oct;13(10):230259. doi: 10.1098/rsob.230259. Epub 2023 Oct 11. Open Biol. 2023. PMID: 37816387 Free PMC article.
-
Trametes robiniophila may induce apoptosis and inhibit MMPs expression in the human gastric carcinoma cell line MKN-45.Oncol Lett. 2017 Feb;13(2):841-846. doi: 10.3892/ol.2016.5517. Epub 2016 Dec 20. Oncol Lett. 2017. PMID: 28356967 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources